A Highly Potent SARS-CoV-2 Blocking Lectin Protein
R. E. Ahan, A. Hanifehnezhad, E. Sahin Kehribar, T. C. Oguzoglu, K. Foldes, C. E. Ozcelik, N. Filazi, S. Oztop, S. C. Onder, E. U. Bozkurt, K. Ergunay, A. Ozkul, U. Seker
This paper demonstrates that griffithsin (GRFT) blocks SARS-CoV-2 entry into cell lines and mouse models by binding to the spike protein, suggesting its potential as a prophylactic drug against SARS-CoV-2 variants.
bioRxiv · Jul 22, 2021Biochemistry